A detailed history of Susquehanna International Group, LLP transactions in Glaukos Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 3,379 shares of GKOS stock, worth $427,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,379
Previous 5,831 42.05%
Holding current value
$427,612
Previous $549,000 27.32%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$89.48 - $118.35 $219,404 - $290,194
-2,452 Reduced 42.05%
3,379 $399,000
Q1 2024

May 07, 2024

SELL
$76.4 - $96.33 $777,904 - $980,832
-10,182 Reduced 63.59%
5,831 $549,000
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $5,179 - $7,404
87 Added 0.55%
16,013 $1.27 Million
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $148,221 - $169,331
2,141 Added 15.53%
15,926 $1.2 Million
Q2 2023

Aug 11, 2023

SELL
$45.44 - $71.21 $3.47 Million - $5.44 Million
-76,451 Reduced 84.72%
13,785 $981,000
Q1 2023

May 16, 2023

BUY
$43.88 - $52.48 $931,616 - $1.11 Million
21,231 Added 30.77%
90,236 $4.52 Million
Q4 2022

Feb 14, 2023

BUY
$40.82 - $57.75 $1.5 Million - $2.12 Million
36,704 Added 113.63%
69,005 $3.01 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $733,420 - $915,836
15,658 Added 94.08%
32,301 $1.72 Million
Q2 2022

Aug 15, 2022

BUY
$34.86 - $63.77 $395,207 - $722,960
11,337 Added 213.66%
16,643 $756,000
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $2.26 Million - $2.95 Million
-51,026 Reduced 90.58%
5,306 $307,000
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $348,093 - $492,621
-8,644 Reduced 13.3%
56,332 $2.5 Million
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $2.32 Million - $4.11 Million
48,830 Added 302.43%
64,976 $3.13 Million
Q2 2021

Aug 11, 2021

SELL
$73.06 - $97.7 $576,954 - $771,536
-7,897 Reduced 32.85%
16,146 $1.37 Million
Q1 2021

May 17, 2021

SELL
$70.43 - $97.42 $197,767 - $273,555
-2,808 Reduced 10.46%
24,043 $2.02 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $3.37 Million - $5.18 Million
-68,877 Reduced 71.95%
26,851 $2.02 Million
Q3 2020

Nov 16, 2020

SELL
$37.23 - $50.97 $820,735 - $1.12 Million
-22,045 Reduced 18.72%
95,728 $4.74 Million
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $3.08 Million - $5.01 Million
106,941 Added 987.27%
117,773 $4.52 Million
Q1 2020

May 15, 2020

SELL
$25.53 - $70.14 $606,873 - $1.67 Million
-23,771 Reduced 68.7%
10,832 $334,000
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $1.01 Million - $1.22 Million
18,622 Added 116.53%
34,603 $1.89 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $151,136 - $216,487
2,580 Added 19.25%
15,981 $999,000
Q2 2019

Aug 16, 2019

BUY
$63.59 - $78.71 $203,678 - $252,108
3,203 Added 31.41%
13,401 $1.01 Million
Q1 2018

May 15, 2018

BUY
$26.05 - $34.5 $265,657 - $351,831
10,198 New
10,198 $314,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.02B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.